Your browser doesn't support javascript.
loading
Serum Galectin-3 in Hepatitis C Virus Infection Declines after Successful Virus Eradication by Direct-Acting Antiviral Therapy.
Weigand, Kilian; Peschel, Georg; Grimm, Jonathan; Müller, Martina; Buechler, Christa.
Afiliação
  • Weigand K; Internal Medicine I Department, Gastroenterology, Hepatology, Endocrinology, Rheumatology and In-fectious Diseases, University Hospital Regensburg, Regensburg; Gastroenterology Department, Gemeinschaftsklinikum Mittelrhein, 56073 Koblenz, Germany. . kilian.weigand@gk.de.
  • Peschel G; Internal Medicine I Department, Gastroenterology, Hepatology, Endocrinology, Rheumatology and In-fectious Diseases, University Hospital Regensburg, Regensburg; Internal Medicine Department, Klinikum Fürstenfeldbruck, 82256 Fürstenfeldbruck, Germany. georg.peschel@ukr.de.
  • Grimm J; Internal Medicine I Department, Gastroenterology, Hepatology, Endocrinology, Rheumatology and In-fectious Diseases, University Hospital Regensburg, Regensburg, Germany. jonathan.grimm@stud.uni-regensburg.de.
  • Müller M; Internal Medicine I Department, Gastroenterology, Hepatology, Endocrinology, Rheumatology and In-fectious Diseases, University Hospital Regensburg, Regensburg, Germany. martina.mueller-schilling@klinik.uni-regensburg.de.
  • Buechler C; Internal Medicine I Department, Gastroenterology, Hepatology, Endocrinology, Rheumatology and In-fectious Diseases, University Hospital Regensburg, Regensburg, Germany. christa.buechler@ukr.de.
J Gastrointestin Liver Dis ; 31(4): 444-452, 2022 12 17.
Article em En | MEDLINE | ID: mdl-36535063
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C Crônica / Galectina 3 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite C Crônica / Galectina 3 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article